by GlobeNewsWire | Aug 26, 2018 | Globe Newswire
REDUCE-IT is the First Study of Any Therapy to Prospectively Enroll and Evaluate Risk Reduction for Cardiovascular Events in Statin-Treated Patients with Elevated Triglyceride Levels and Other Cardiovascular Risk FactorsREDUCE-IT Study Remains On-Track for Report of...